Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
AVBCC COVID-19 Webcast Series
Economics & Value
First National Study: Geographic Socioeconomic Disparities Mirror Substantial Gaps in Survival in Children with AML
Chase Doyle
Real-World Healthcare Utilization and Costs Support Broader Use of CAR T-Cell Therapy
Phoebe Starr
Value-Based Care Management Medicare Program Changes for 2020 and Beyond
Joseph S. Bailes, MD
,
Gena Cook
View More Articles
Personalized Medicine
Loss of Y Chromosome in Men Makes Bladder Cancer More Aggressive
Nadia Jaber
Liquid Biopsies on the Horizon for Children With Solid Cancers
Ella Ben-Ari
Recent Developments in Genomic-Driven Therapies for Cholangiocarcinoma
View More Articles
Value in Oncology
NCCN Panel Debates Cancer Care in Value-Based Healthcare Models
Wayne Kuznar
FDA Implements New Steps to Encourage Generic Drug Competition, Expand Patients’ Access to Inexpensive Medicines
Eileen Koutnik-Fotopoulos
Rapid Adoption of Oncology Drugs Improves Survival
Chase Doyle
View More Articles
FDA Approvals, News & Updates
Fruzaqla FDA Approved for Relapsed Metastatic Colorectal Cancer
FDA Approved Loqtorzi, a PD-1 Inhibitor, for the Treatment of Metastatic or Recurrent Nasopharyngeal Carcinoma
Keytruda Plus Chemotherapy Receives New FDA Approvals for Advanced Biliary Tract Cancer and 2 Forms of GEJ Adenocarcinoma
View More Articles
Emerging Therapies
Zanidatamab Demonstrates Efficacy in Refractory HER2-Amplified Biliary Tract Cancer
Investigational mRNA-Based Vaccine May Offer New Hope for Patients With High-Risk Melanoma
Phoebe Starr
First-Line Mosunetuzumab Safe and Effective in Older Patients with Diffuse Large B-Cell Lymphoma
Chase Doyle
View More Articles
Immunotherapy
Immunotherapy After Surgery Shows Long-Term Benefits for High-Risk Bladder Cancer
Sharon Reynolds
Personalized Vaccine plus Immune Checkpoint Inhibitor a Promising Approach to Cancer
Phoebe Starr
FDA Grants Priority Review to Keytruda for Patients with High-Risk, Non–Muscle-Invasive Bladder Cancer
Yvette Florio Lane
View More Articles
July 22, 2020: Patient Advocacy Update: COVID-19 Recovery, the Road Ahead
By
Elizabeth Franklin, LGSW, ACSW
;
Patricia J Goldsmith
;
Amy Niles, MBA
;
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
As the COVID-19 pandemic stretches into its fifth month in the United States, advocacy groups providing support for patients with cancer are delivering essential support and services, while they worry about the long-term psychosocial impact on these patients and the future of clinical trials.
Read Article
July 21, 2020: Oncology Pharmacy Update: COVID-19 Recovery, the Road Ahead
By
Scott Freeswick, MS, PharmD
;
Niesha Griffith, RPh, MS, FASHP
;
Chris Marcum, PharmD
;
Ali McBride, PharmD, MBA
;
Stacey McCullough, PharmD
;
Bhavesh Shah, RPh, BCOP
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
Shortages, inventory management, and challenges of in-home care were just a few of the topics in AVBCC’s wide-ranging webinar on how COVID-19 is affecting oncology pharmacy.
Read Article
Oncology Home Infusions in the Post–COVID-19 World
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
The COVID-19 pandemic has led to the elimination of several restrictions on telehealth and infusion therapy in the home setting. In this webcast, a panel of experts discuss the short- and long-term prospects for in-home infusion for patients with cancer. What are the benefits and drawbacks?
Read Article
Potential for Anti-Cancer Agents in the Treatment of COVID-19
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
As we learn more about the complicated behavior of the COVID-19 virus, we have come to understand that overactivation of the patient’s own immune system can often be the most dangerous factor. In this webcast, top cancer experts discuss the latest studies investigating using anti-cancer therapies as treatments for COVID-19. What are some of the options and where does the research stand today?
Read Article
July 15, 2020: Oncology Home Infusion in Post-COVID-19 World: COVID-19 Recovery, the Road Ahead
By
Roger Brito, DO
;
Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP, FAAN
;
Michael Kolodziej, MD
;
Barbara L. McAneny, MD
;
Steven Peskin, MD, MBA, FACP
;
Chevon Rariy, MD
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
The COVID-19 pandemic has led to the elimination of several restrictions on telehealth and infusion therapy in the home setting. In this webcast, a panel of experts discuss the short- and long-term prospects for in-home infusion for patients with cancer. What are the benefits and drawbacks?
Read Article
July 14, 2020: Potential For Cancer Agents in the Treatment of COVID-19: COVID-19 Recovery, the Road Ahead
By
David DeRemer, PharmD, BCOP, FCCP, FHOPA
;
Michael Joyner, MD
;
Maurie Markman, MD
;
Kevin O’Hayer, MD, PhD
;
Bhavesh Shah, RPh, BCOP
;
Mark Sloan, MD
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
As we learn more about the complicated behavior of the COVID-19 virus, we have come to understand that overactivation of the patient’s own immune system can often be the most dangerous factor. In this webcast, top cancer experts discuss the latest studies investigating using anti-cancer therapies as treatments for COVID-19. What are some of the options and where does the research stand today?
Read Article
Economic Impact of the COVID-19 Crisis
COVID-19
The COVID-19 pandemic will have far-reaching economic implications in the United States and abroad for the foreseeable future. During this session Murray Aitken, MBA, Director, IQVIA Institute, presented emerging data regarding some of the ways in which the pandemic is affecting the US economy.
Read Article
Actuarial View of COVID-19: Payers, Providers, and Healthcare Reform
COVID-19
Burt Zweigenhaft, PhD, D.Litt, Founder, Association for Value-Based Cancer Care, moderated a panel session in which 3 experts from the independent actuarial firm, Milliman, discussed recent data showing the ways in which the COVID-19 pandemic may affect the future of healthcare.
Read Article
May 27, 2020: An Actuarial View of COVID-19: Payers, Providers, Healthcare Reform: COVID-19 Impact on Cancer Care and Road to Recovery
By
Gabriela Dieguez, FSA, MAAA
;
Pamela Pelizzari, MPH
;
Bruce S. Pyenson, FSA, MAAA
;
Burt Zweigenhaft, PhD, D.Litt
AVBCC COVID-19 Webcast Series Replays
,
COVID-19
In this webcast, 3 experts from the independent actuarial firm, Milliman, discussed data on the impact of the COVID-19 pandemic on insurance utilization and costs. The panel explored several factors that may lead to healthcare reform in the months ahead, including the way in which patients and providers approach deferred or avoidable care.
Read Article
Washington and COVID-19: The Government Response
AVBCC COVID-19 Webcast Series Coverage
,
COVID-19
The federal government is an active participant in shaping and delivering healthcare policy. The panelists in this session addressed the government’s response to COVID-19 and weighed in on some of the issues that their agencies frequently encountered as medical practices grapple with the new normal.
Read Article
Page 4 of 8
1
2
3
4
5
6
7
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani
,
Arva Patel
,
Warner Kornberg
,
Asutosh Gor, MD
,
Sashi Naidu, MD
,
Viral Rabara, MD
,
Niyati Nathwani, MD
,
Kashyap Patel, MD
2.
Navigating the Complex Landscape of Oral Cancer Medication
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma